Biogenic Peptides and Their Potential Use
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1345-1355
Author(s):
Naoyuki Yamamoto, Masahiro Ejiri and Seiichi Mizuno
Pharmacokinetics of Topical Ocular Drug Delivery: Potential Uses for the Treatment of Diseases of the Posterior Segment and Beyond
Journal:
Current Drug Metabolism
Volume:
4
Page:
213-222
Author(s):
Steven B. Koevary
Ca2+-Handling Proteins and Heart Failure: Novel Molecular Targets?
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
967-981
Author(s):
J. Prestle, F. R. Quinn and G. L. Smith
Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
211-219
Author(s):
A. Evangeliou and D. Vlassopoulos
Stroke: Molecular Mechanisms and Potential Targets for Treatment
Journal:
Current Molecular Medicine
Volume:
3
Page:
361-372
Author(s):
Z. Zheng, J. E. Lee and M. A. Yenari
Therapeutic Angiogenesis in Ischemic Heart Disease: Gene or Recombinant Vascular Growth Factor Protein Therapy?
Journal:
Current Gene Therapy
Volume:
3
Page:
197-206
Author(s):
Jens Kastrup
Neuronal Generation from Somatic Stem Cells: Current Knowledge and Perspectives on the Treatment of Acquired and Degenerative Central Nervous System Disorders
Journal:
Current Gene Therapy
Volume:
3
Page:
247-272
Author(s):
S. Corti, F. Locatelli, S. Strazzer, M. Guglieri and G. P. Comi
Pharmacologic Strategies for Suppression of Lipid Peroxidation in Neurodegeneration
Journal:
Current Neuropharmacology
Volume:
1
Page:
125-134
Author(s):
K. S. Montine, D. Milatovic, M. Doherty, J. D. Morrow and T. J. Montine
Limiting Functional Deficiency Following Stroke: Exploiting Different Stem Cell Reservoirs
Journal:
Current Neuropharmacology
Volume:
1
Page:
135-152
Author(s):
David A. Stevens, Stephen D. Skaper and Andrew A. Parsons
Is Impaired Flow-Mediated Dilatation of the Brachial Artery a Cardiovascular Risk Factor?
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
107-109
Author(s):
Stefan Agewall